STX4

STX4 is a plasma-membrane t-SNARE that assembles into SNARE complexes with SNAP23 and cognate R-SNAREs to drive regulated vesicle fusion across multiple secretory and exocytic contexts (PMID:21586284, PMID:18439908). In macrophages it partners with VAMP3 and SNAP23 to mediate polarised exocytosis of recycling-endosome membrane, organising podosome superstructures and supporting adhesion, spreading, and persistent migration (PMID:21586284). In insulin-responsive cells its engagement of VAMP2 is gated by Synip, which binds STX4 outside its N-terminal 1–28 residues and blocks VAMP2 association until insulin triggers Synip dissociation, licensing SNARE assembly and GLUT4 vesicle fusion (PMID:18439908). STX4 is also required for VAMP2+ vesicle docking at the cardiomyocyte sarcolemma and for L-type Ca2+ channel modulation, and the human STX4 R240W variant behaves as a hypomorphic allele causing cardiac electrical and morphological defects in a zebrafish model (PMID:35599850). Beyond the plasma membrane, STX4 localises to the outer mitochondrial membrane in skeletal muscle, where it binds Drp1 and promotes AMPK-mediated phosphorylation of Drp1 at S637 to favour mitochondrial fusion and prevent diet-induced mitochondrial fragmentation and insulin resistance (PMID:35058456); inducible muscle-specific loss of STX4 impairs mitochondrial biogenesis and mitophagy, establishing a role in mitochondrial quality control distinct from its SNARE function (PMID:41214862). STX4 contributes selectively to membrane-fusion pathways: it is dispensable for Sec22b-dependent ER-to-endosome fusion during APC cross-presentation (PMID:37638825).

1. 2008 Medium

   Established how STX4 availability for SNARE assembly is regulated, showing that Synip gates VAMP2 access to STX4 and that insulin relieves this block to permit GLUT4 vesicle fusion.

   Evidence in vitro co-expression/co-purification of a 1:1 complex with N-terminal deletion mapping of Stx4

   PMID:18439908

   Open questions at the time

   • In vitro reconstitution from a single lab without cellular validation of the gating model
   • Structural basis of the Synip-binding region beyond exclusion of residues 1-28 not resolved
   • Does not address other regulated fusion contexts
2. 2011 Medium

   Defined a complete plasma-membrane SNARE complex for STX4 and tied it to a discrete cellular process, demonstrating STX4/SNAP23/VAMP3 mediate recycling-endosome exocytosis for macrophage spreading and migration.

   Evidence siRNA knockdown of each SNARE component in macrophages with live imaging, podosome morphology, and fibronectin migration assays

   PMID:21586284

   Open questions at the time

   • Direct demonstration of the ternary complex in macrophages not shown biochemically
   • Recruitment mechanism to migration sites unknown
   • Single cell type
3. 2022 High

   Revealed a non-canonical mitochondrial function for STX4, showing it localises to the outer mitochondrial membrane, binds Drp1, and drives AMPK-mediated Drp1-S637 phosphorylation to favour fusion and protect against metabolic dysfunction.

   Evidence EM localisation, reciprocal Co-IP, transgenic muscle-specific STX4 enrichment with HFD challenge, phospho-Drp1 S637 immunoblotting

   PMID:35058456

   Open questions at the time

   • Mechanism by which STX4 promotes AMPK activity on Drp1 not resolved
   • Whether SNARE function is involved in mitochondrial targeting unclear
   • Single tissue (skeletal muscle)
4. 2022 Medium

   Linked STX4 to cardiac development and human disease, showing it is required for sarcolemmal VAMP2+ vesicle docking and L-type Ca2+ channel modulation and that the R240W variant is hypomorphic.

   Evidence CRISPR stx4 knockout zebrafish, live vesicle-docking imaging, optical cardiac mapping, pharmacological Ca2+ modulation, R241W transgenic overexpression

   PMID:35599850

   Open questions at the time

   • Molecular link between vesicle docking and Ca2+ channel modulation not defined
   • Human variant pathogenicity tested only in zebrafish surrogate
   • Cognate R-SNARE for cardiac fusion not confirmed beyond VAMP2 association
5. 2023 Medium

   Delimited STX4's fusion repertoire, showing it is dispensable for Sec22b-dependent ER-to-endosome fusion during cytosolic-pathway cross-presentation in APCs.

   Evidence CRISPR/Cas9 Stx4 knockout in two murine APC lines with cross-presentation CTL assay

   PMID:37638825

   Open questions at the time

   • Negative result limited to the tested cross-presentation context
   • Possible redundancy with other syntaxins not excluded
   • Does not address other immune fusion events
6. 2025 Medium

   Demonstrated STX4 is required for mitochondrial quality control, with inducible muscle-specific loss impairing both mitochondrial biogenesis and mitophagy.

   Evidence inducible skmSTX4-iKO mice and myotube siRNA, mt-Keima mitophagy biosensor, ETC immunoblotting, oxygen consumption, [U-13C]glucose tracing

   PMID:41214862

   Open questions at the time

   • Direct molecular role of STX4 in PINK1/PARKIN recruitment or PGC1-alpha regulation not established
   • Whether biogenesis and mitophagy defects are secondary to fission/fusion imbalance unclear
   • Single tissue
7. 2025 Low

   Extended STX4's exocytic role to secretory autophagy, placing it as a plasma-membrane Q-SNARE with SNAP23 that fuses UBB+1-containing autophagosomes via the R-SNARE SEC22B.

   Evidence CRISPR/siRNA knockdown of STX4, SNAP23, SEC22B in cultured cells with UBB+1 secretion assay and co-localisation imaging (preprint)

   PMID:bio_10.1101_2024.12.31.630908

   Open questions at the time

   • Preprint with limited mechanistic detail; not peer-reviewed
   • Direct SNARE complex formation not demonstrated biochemically
   • Cargo selectivity for UBB+1 unexplained
8. 2025 Low

   Associated STX4 with ovarian cancer cell behaviour, linking its silencing to reduced EMT and proliferation markers.

   Evidence lentiviral shRNA knockdown in SK-OV-3 and CAOV-3 cells, CCK-8/Transwell/scratch assays, EMT/MMP2/CCND1 immunoblotting, xenograft

   PMID:40483481

   Open questions at the time

   • Pathway placement inferred from marker levels without epistasis
   • Direct mechanistic link between SNARE function and EMT signalling not established
   • Single study

• How STX4 partitions between plasma-membrane SNARE assembly and outer-mitochondrial Drp1 regulation, and whether these functions share a common molecular determinant, remains unresolved.
• Targeting signals directing STX4 to mitochondria versus plasma membrane unknown
• No structural model unifying its SNARE and Drp1-regulatory activities
• Whether mitochondrial functions require SNARE-domain interactions untested